CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Operating Activities:
Net income	$ 81,188	$ 77,318
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	42,629	39,985
Allowance for doubtful accounts	2	(3)
Loss on sale of property and equipment	1,274	522
Deferred income taxes	(1,557)	(371)
Equity in losses (gains) of unconsolidated affiliates	22	(79)
Stock-based compensation	9,022	8,100
Change in operating assets and liabilities:
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals	1,339	(19,224)
Merchandise inventories	(21,009)	(30,885)
Accounts payable	13,475	52,303
Net cash provided by operating activities	126,385	127,666
Investing Activities:
Additions to property and equipment	(62,812)	(103,477)
Purchases of short-term investments	(68,248)	(98,833)
Proceeds from settlements of short-term investments	51,310	96,945
Proceeds from disposal of property and equipment	242	101
Net cash used in investing activities	(79,508)	(105,264)
Financing Activities:
Proceeds from long-term bank borrowings	5,441	16,500
Repayment of long-term bank borrowings	(28,298)	(16,383)
Proceeds from short-term bank borrowings	7,574	0
Repayment of short-term bank borrowings	(318)	(2,941)
Cash dividend payments	(19,376)	(17,781)
Purchase of treasury stock	(5,752)	(71,738)
Net cash used in financing activities	(40,729)	(92,343)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	3,045	314
Net increase (decrease) in cash, cash equivalents	9,193	(69,627)
Cash, cash equivalents and restricted cash at beginning of period	136,311	252,202
Cash, cash equivalents and restricted cash at end of period	145,504	182,575
Supplemental disclosure of noncash investing activities:
Capital expenditures accrued, but not yet paid	3,066	6,075
Dividends declared but not yet paid	19,411	17,771
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	130,363	170,563
Short-term restricted cash	3,476	2,834
Long-term restricted cash	11,665	9,178
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$ 145,504	$ 182,575